Elicio Therapeutics News

Elicio Therapeutics Advances ELI-002 and Secures Funding

TipRanksDec 12, 2024 07:29 ET

Elicio Therapeutics Presents Updated Results From ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

GlobeNewswireDec 12, 2024 07:00 ET

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

GlobeNewswireDec 3, 2024 07:00 ET

Express News | Elicio Therapeutics Announces Completion of Phase 2 Amplify-7P Study Enrollment

ReutersDec 3, 2024 07:00 ET

Express News | Elicio Therapeutics Inc: Expects Current Cash and Cash Equivalents to Support Operations Into Q2 of 2025

ReutersNov 13, 2024 16:27 ET

Express News | Elicio Therapeutics Q3 2024 GAAP EPS $(1.39) Misses $(0.73) Estimate

BenzingaNov 13, 2024 16:26 ET

Elicio Therapeutics Reports Q3 EPS ($1.39), Consensus (73c)

TipRanksNov 13, 2024 16:25 ET

Elicio Therapeutics Files to Sell 3.44M Shares of Common Stock for Holders

TipRanksNov 13, 2024 16:25 ET

Express News | Elicio Therapeutics Inc Files for Offering of up to 3.4 Mln Shares by the Selling Stockholder - SEC Filing

ReutersNov 13, 2024 16:22 ET

Elicio Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 13, 2024 16:17 ET · Announcements

Express News | Elicio Therapeutics Q3 Income From Operations USD -10.344 Million

ReutersNov 13, 2024 16:05 ET

Press Release: Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Dow JonesNov 13, 2024 16:05 ET

JonesTrading Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 8, 2024 13:31 ET · Ratings

Elicio Therapeutics Presents Updated Preliminary Results From AMPLIFY-7P

TipRanksNov 7, 2024 18:40 ET

Express News | Elicio Therapeutics Shares ELI-002 Phase 1 Data At SITC 2024; Preliminary Results Show Dose-Dependent T Cell Responses Targeting KRAS Mutations And Link To Disease-Free Survival

BenzingaNov 7, 2024 17:35 ET

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

GlobeNewswireOct 31, 2024 08:30 ET

JonesTrading Initiates Elicio Therapeutics(ELTX.US) With Buy Rating, Announces Target Price $9

Moomoo NewsOct 30, 2024 16:31 ET · Ratings

All You Need to Know About Elicio Therapeutics (ELTX) Rating Upgrade to Strong Buy

Yahoo FinanceOct 24, 2024 12:00 ET

Express News | Elicio Therapeutics: Appoints Robert Connelly as Principal Financial Officer

ReutersOct 17, 2024 08:33 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaOct 1, 2024 08:07 ET